C123H108BrCl4F3N32O9 — CID 159786778
(2S)-2-acetamido-N-(1H-indazol-5-yl)-2-phenylacetamide;2-amino-2-(3-bromophenyl)-N-(1H-indazol-5-yl)acetamide;2-amino-2-(3-chlorophenyl)-N-(1H-indazol-5-yl)acetamide;2-amino-2-(4-chlorophenyl)-N-(1H-indazol-5-yl)acetamide;2-amino-2-(3,4-dichlorophenyl)-N-(1H-indazol-5-yl)acetamide;(2R)-2-amino-N-(1H-indazol-5-yl)-2-phenylacetamide;(2S)-2-amino-N-(1H-indazol-5-yl)-2-phenylacetamide;2-amino-N-(1H-indazol-5-yl)-2-[3-(trifluoromethyl)phenyl]acetamide (PubChem CID 159786778) has the molecular formula C123H108BrCl4F3N32O9 and a molecular weight of 2457.14 g/mol. Its IUPAC name is (2S)-2-acetamido-N-(1H-indazol-5-yl)-2-phenylacetamide;2-amino-2-(3-bromophenyl)-N-(1H-indazol-5-yl)acetamide;2-amino-2-(3-chlorophenyl)-N-(1H-indazol-5-yl)acetamide;2-amino-2-(4-chlorophenyl)-N-(1H-indazol-5-yl)acetamide;2-amino-2-(3,4-dichlorophenyl)-N-(1H-indazol-5-yl)acetamide;(2R)-2-amino-N-(1H-indazol-5-yl)-2-phenylacetamide;(2S)-2-amino-N-(1H-indazol-5-yl)-2-phenylacetamide;2-amino-N-(1H-indazol-5-yl)-2-[3-(trifluoromethyl)phenyl]acetamide.
| Compound Name | (2S)-2-acetamido-N-(1H-indazol-5-yl)-2-phenylacetamide;2-amino-2-(3-bromophenyl)-N-(1H-indazol-5-yl)acetamide;2-amino-2-(3-chlorophenyl)-N-(1H-indazol-5-yl)acetamide;2-amino-2-(4-chlorophenyl)-N-(1H-indazol-5-yl)acetamide;2-amino-2-(3,4-dichlorophenyl)-N-(1H-indazol-5-yl)acetamide;(2R)-2-amino-N-(1H-indazol-5-yl)-2-phenylacetamide;(2S)-2-amino-N-(1H-indazol-5-yl)-2-phenylacetamide;2-amino-N-(1H-indazol-5-yl)-2-[3-(trifluoromethyl)phenyl]acetamide |
|---|---|
| PubChem CID | 159786778 |
| Molecular Formula | C123H108BrCl4F3N32O9 |
| Molecular Weight | 2457.14 g/mol |
| Exact Mass | 2452.69 |
| IUPAC Name | (2S)-2-acetamido-N-(1H-indazol-5-yl)-2-phenylacetamide;2-amino-2-(3-bromophenyl)-N-(1H-indazol-5-yl)acetamide;2-amino-2-(3-chlorophenyl)-N-(1H-indazol-5-yl)acetamide;2-amino-2-(4-chlorophenyl)-N-(1H-indazol-5-yl)acetamide;2-amino-2-(3,4-dichlorophenyl)-N-(1H-indazol-5-yl)acetamide;(2R)-2-amino-N-(1H-indazol-5-yl)-2-phenylacetamide;(2S)-2-amino-N-(1H-indazol-5-yl)-2-phenylacetamide;2-amino-N-(1H-indazol-5-yl)-2-[3-(trifluoromethyl)phenyl]acetamide |
| SMILES | CC(=O)N[C@H](C(=O)Nc1ccc2[nH]ncc2c1)c1ccccc1.NC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1.NC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1.NC(C(=O)Nc1ccc2[nH]ncc2c1)c1cccc(Br)c1.NC(C(=O)Nc1ccc2[nH]ncc2c1)c1cccc(C(F)(F)F)c1.NC(C(=O)Nc1ccc2[nH]ncc2c1)c1cccc(Cl)c1.N[C@@H](C(=O)Nc1ccc2[nH]ncc2c1)c1ccccc1.N[C@H](C(=O)Nc1ccc2[nH]ncc2c1)c1ccccc1 |
| InChI | InChI=1S/C17H16N4O2.C16H13F3N4O.C15H13BrN4O.C15H12Cl2N4O.2C15H13ClN4O.2C15H14N4O/c1-11(22)19-16(12-5-3-2-4-6-12)17(23)20-14-7-8-15-13(9-14)10-18-21-15;17-16(18,19)11-3-1-2-9(6-11)14(20)15(24)22-12-4-5-13-10(7-12)8-21-23-13;16-11-3-1-2-9(6-11)14(17)15(21)19-12-4-5-13-10(7-12)8-18-20-13;16-11-3-1-8(6-12(11)17)14(18)15(22)20-10-2-4-13-9(5-10)7-19-21-13;16-11-3-1-9(2-4-11)14(17)15(21)19-12-5-6-13-10(7-12)8-18-20-13;16-11-3-1-2-9(6-11)14(17)15(21)19-12-4-5-13-10(7-12)8-18-20-13;2*16-14(10-4-2-1-3-5-10)15(20)18-12-6-7-13-11(8-12)9-17-19-13/h2-10,16H,1H3,(H,18,21)(H,19,22)(H,20,23);1-8,14H,20H2,(H,21,23)(H,22,24);1-8,14H,17H2,(H,18,20)(H,19,21);1-7,14H,18H2,(H,19,21)(H,20,22);2*1-8,14H,17H2,(H,18,20)(H,19,21);2*1-9,14H,16H2,(H,17,19)(H,18,20)/t16-;;;;;;2*14-/m0.....10/s1 |
| InChIKey | NIAXSGWXUYSXEJ-QVMUJRFSSA-N |
| XLogP | 22.18 |
| TPSA | 673.48 Ų |
| H-Bond Donors | 24 |
| H-Bond Acceptors | 24 |
| Rotatable Bonds | 25 |
| Heavy Atoms | 172 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2457.14 |
| LogP ≤ 5 | 22.18 |
| H-Bond Donors ≤ 5 | 24 |
| H-Bond Acceptors ≤ 10 | 24 |